This message was sent to ##Email##
Registration for the ASHI 43rd Annual Meeting being held at the Hilton San Francisco Union Square on September 11-15, 2017 is now open!
Register by Thursday, July 20th to take advantage of our early registration rates.
Click here to download the complete registration brochure!
Click here to view more information regarding registration rates and how to register today!
Book Your Hotel Now!
Housing is now available for the ASHI 43rd Annual Meeting in San Francisco. Housing is available on a first-come, first-served basis. Book your housing today to guarantee your room!
Click here for more information on hotel room rates and how to book online.
Song Requests Welcome!
There is a NEW Networking Event this year at the ASHI 43rd Annual Meeting. You can go to eat dinner wherever you would like, but then return to have deserts, drinks, and dancing with the one and only Dorry Segev as our DJ on Thursday, September 14th at 9:00 PM. Dorry is a transplant surgeon from John Hopkins Medical Center who has been a DJ at several transplant-related, highly enjoyable parties. Dorry will be collecting requests for songs over the next few months and he will lead our party on Thursday evening. There is no additional cost associated with participating in this event!
See you at the Networking Event!
Thursday, September 14, 2017
9:00 PM - 11:00 PM
Click here to submit a song request!
|Regional Educational Workshop 2
The preliminary program for the ASHI Regional Education Workshop 2 is now available! Click here to view the preliminary program.
Regional Workshop 2 Keynote Address: Dr. Joren Madsen
Join us Thursday evening for the Regional Workshop 2 Welcome Reception and Keynote Address, Dr. Joren Madsen from Massachusetts General Hospital, from 6:30 - 8:30 pm in the Rosemore Ballroom.
Dr. Joren C. Madsen, the Paul S. Russell/Warner-Lambert Professor of Surgery at Harvard Medical School, is a heart transplant surgeon with a strong research interest in transplant immunology. He is currently the director of the MGH Transplant Center and co-director of the MGH Center for Transplantation Sciences.
Make Hotel Reservation
The next generation of Virtual Crossmatch is here!
VXmatch is a web and mobile-enabled application that displays all the crossmatch data you want; in exactly the way you want it. Want DSA trends, dilution, reactivity history, and graphs? VXmatch is a virtual crossmatch for labs who take it seriously.
The Travel Fund Award was created to help newer ASHI members attend regional and annual meetings. For the 2017 annual meeting, 2 additional grants have been added for Technologist members to attend so there are now four grants available for Technologist members and two for Doctoral level members. Winners of a 2017 ASHI Travel Fund Award will receive:
|ASHI Travel Awards Available for the Annual Meeting — Apply Now!
*Limited to one travel fund award per institution each year.
- One (1) complimentary registration to the 2017 ASHI Annual Meeting
- Up to $1,000 reimbursement to the 2017 Annual Meeting (must be in compliance with the ASHI travel policy).
To be considered for the ASHI Travel Fund Award you must be a current ASHI member of five (5) years or less. The following increase your likelihood of being chosen:
Please complete this application. Once we receive your application, we will contact your General Supervisor or Director for verification of support for your application. These items will be sent to the reviewing committee. Good luck!
- Volunteer service to ASHI and/or ABHI
- Presentations at ASHI meetings
- Authorship in ASHI publications
- Desire to further your career in HLA
APPLICATION DEADLINE is July 7, 2017
The ballots for the 2017 board election and proposed bylaws amendments have been mailed to all Full Doctoral and Full Non-doctoral members. This year, a self-addressed, stamped, return envelope has been included so you only need to make your selections on the ballot, and mail the completed ballot in the return envelope back to ASHI headquarters. Ballots received after July 17, 2017 will not be valid.
The EMO survey was shipped on May 9th. The results submission due date for this survey is June 9, 2017.
The performance and summary reports for the HT-1 will be available soon.
To learn more about ASHI's PT Program, click here.
Take a few moments to renew your 2017 ASHI membership today to avoid disruption of your ASHI benefits. Your membership dues allow us to provide programs, professional awards, and educational opportunities that advance the science, education and application of immunogenetics and transplant immunology. Renew Online Today!
|Don't Let Your ASHI Membership Expire!
The ASHI Distinguished Service Award was established in 1999 to honor colleagues who have contributed significantly to ASHI's heritage. This award recognizes:
The ASHI Distinguished Scientist Award was established in 2001 to honor a distinguished scientist who is an ASHI member. This individual must have contributed significantly to the field of immunogenetics and/or transplant immunology. This award recognizes:
- ASHI membership past or present, doctoral or non-doctoral
- Creativity in moving ASHI in new directions, both scientifically and as an organization
- Service to ASHI
- Educational contribution on behalf of ASHI
The Rose Payne Award recognizes distinguished scientific accomplishment and extraordinary contributions to the immunogenetics community. Specifically, this award recognizes contributions to the advancement of histocompatibility and immunogenetics and other extraordinary contributions.
- ASHI membership past or present
- Professional scientific accomplishments: theoretical and technical creativity
- Special contributions and achievements in their field of expertise
- Other extraordinary contributions
The Outstanding Technologist Award is presented annually to a technologist who has provided outstanding contributions to the field of histocompatibility and immunogenetics.
Click here to read the nomination requirements for all awards and then submit your nominations now to Katherine Miranda.
THE NOMINATIONS DEADLINE IS JUNE 1, 2017.
To view a list of former award winners, please click here.
Are you a technologist who has worked in the HLA field for less than three years? Are you looking forward to a career in HLA? By sharing your HLA story with us, you could win ASHI's 2017 Rising Star Award!
|Rising Star Essays Due June 1st!
The Rising Star Award recognizes an outstanding HLA technologist who has worked in the field for less than three years and desires to pursue a career in HLA. The requirement for this award is a short essay (less than four pages) describing your current work in HLA and why you are interested in pursuing a career in the field. This essay must be written by you, the nominee, and validated by your director or direct supervisor.
The winner will receive:
To be considered for this year's Rising Star Award, submit your essay by June 1, 2017 to Katherine Miranda at ASHI Headquarters.
- One (1) complimentary registration to the 2017 ASHI Annual Meeting in San Francisco
- Two (2) nights hotel stay at the Hilton San Francisco Union Square
- Up to $700 airfare in compliance with the ASHI travel policy
- A plaque which will be presented to you at the ASHI Annual Meeting during the Awards & Business Meeting
- One (1) year ASHI technologist membership. If you are already an ASHI member, your membership will be extended for one year.
To view former award winners, please click here.
This is an update to the notice originally distributed by UNOS on May 2. It solely addresses OPTN requirements for pre-transplant crossmatches and does not represent any change in OPTN policy. NOTE: CMS regulation 42 CFR 493.1278(f)(2) specifically addresses crossmatch requirements. The information below is not meant to apply to any interpretation of CMS requirements or any ongoing discussion of how to interpret CMS regulation.
OPTN Policy 4.6 lists the requirements for histocompatibility laboratories to perform a pre-transplant final crossmatch for all transplants involving a kidney (including multi-organ transplants) and to report the results to the transplant program prior to transplantation. OPTN Policy 13.10 also requires a final pre-transplant crossmatch for transplant centers intending to perform a kidney paired donation transplant. Additionally, the specifications for the crossmatch and reporting of results must be delineated in the written agreement between the histocompatibility laboratory and the transplant program(s) it supports, as stated in Bylaw Appendix C.2.
OPTN Policy 4.10 provides reference tables of equivalences for HLA antigens and alleles. The UNetSM match system uses the tables for a variety of purposes. These purposes include, but are not limited to, determining candidate priority for allocation of a 0-ABDR mismatched graft; assessing DR mismatch point assignments; and preventing incompatible candidates from appearing on match runs via listing of unacceptable/avoid antigens. However, please note:
If you have additional questions or need further information on this subject, please contact your Regional Administrator. Contact information for your Regional Administrator is available in Transplant Pro.
- The match system does not fulfill the requirement for performing a pre-transplant final crossmatch. UNetSM is neither designed for, nor intended to predict whether an individual organ offer will result in an acceptable transplant. It is recommended that the final determination of immunologic compatibility be made by the transplant program in conjunction with its histocompatibility laboratory director. The individual histocompatibility laboratory is still responsible for performing a pre-transplant final crossmatch as specified in Policy 4.6 and in accordance with the written agreement for the transplant program(s) it supports.
- While the equivalency tables are reviewed and updated on a regular basis, they may not address additional clinically significant findings that may impact the decision to transplant/not transplant a particular candidate. Moreover, the tables cannot account for any recent advances in the field of histocompatibility that may impact a transplant decision.
The latest release of the 17th International Histocompatibility & Immunogenetics Workshop and Conference newsletter, IHIWS Connects, is now available. This issue features registration instructions for attending the 17th IHIWS in Pacific Grove, California, as well as important updates about the progress of workshop components and projects. To read this and all prior IHIWS Connects newsletters, visit: http://ihiws.org/newsletters/
Elsevier, publisher of ASHI's scientific publication, Human Immunology, offers online education to authors. Here you'll find free online lectures, interactive training courses, expert advice and other resources to support you in publishing your journal article or world-class book. Certificates to recognize your efforts are available.
Name & Credentials: Kelley M.K. Hitchman, M.S., Ph.D., D(ABHI)
Job title and place of employment: Section Chief and Director, HLA - University of Texas Health Science Center
Graduated from: Iowa State University and Southern Illinois University
How long have you been an ASHI member? 4 years
If you would like to be featured in an upcoming Member Spotlight, please complete the online form.
ASHI and the Association of Medical Laboratory Immunologists (AMLI) are hosting an exciting Member Society symposium at the 17th Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS 2017) on Wednesday, June 14, at the Hilton Downtown Chicago Hotel. First held in 2001, the FOCIS Annual Meeting draws the best clinician scientists from around the world to participate in the scientific program, bringing together cutting-edge science from various disease fields related to clinical immunology.
With an innovative lineup of topics and presenters, the FOCIS 2017 program has something for everyone! Registration is open and travel awards are available to top-scoring late-breaking posters.
Hope to see you in Chicago!
The 2017 International Summer School meeting, jointly sponsored and produced by EFI, ASHI, and APHIA, will be held at Trinity College in the heart of the city of Dublin, Ireland, July 24-26th, 2017.
The International Summer School (ISS) provides a focused course on all aspects of theoretical and applied immunogenetics and histocompatibility. To encourage discussion, the course is limited to a small number of participants (30-40). Participants are invited to present their own research. This meeting is a great opportunity for those seeking higher education in histocompatibility and immunogenetics as well as a chance to meet others working in the field from different parts of the world.
ASHI will be awarding two travel stipends to attend the International Summer School. If you are an ASHI member, please contact us for an ISS application at firstname.lastname@example.org.
Click here for more information!
44TH ANNUAL MEETING
October 1-5, 2018
Baltimore Marriott Waterfront
45TH ANNUAL MEETING
September 23-27, 2019
David L. Lawrence Convention Center
46TH ANNUAL MEETING
October 19-23, 2020
You must log in to access the members only Forums.
If you would like to receive updates as content is posted, you must subscribe by clicking the Forum Actions Box at the top of the Forum page and subscribe to instant updates or/and click to subscribe to the Digest to get updates.
Click here for detailed instructions
Why not join the conversation? Login here.
Current Forum topics being discussed include:
- HLA Laboratory Business Model
- Complement binding antibodies and 1:16 serum dilution
- DP Antibody in Heart Tx
- Justifying the need for another HLA tech
- SAB Testing
- Contacting Patients for Serum Specimens
- What current challenges are you facing as a technologist?
- Easy Sep Bead Preparation for Flow Crossmatching
- How did you get started in HLA?
- NMDP codes
- Continuing Education
Endothelial cell antigens have been reported as potential targets for antibodies in the context of organ transplantation, leading to increased risk for graft failure. Serum samples from 142 consecutive living donor kidney recipients were tested for the presence of antibodies to angiotensin II – type 1 receptor (AT1R), donor endothelial cells, and donor HLA. Graft survival was monitored for five years post-transplant, and secondary outcomes, including biopsy-proven rejection, proteinuria, biopsy-proven vasculopathy, and renal function based on serum creatinine were also assessed for the first two to three years.
American Journal of Transplantation
We report the first two cases of post-transplant lymphoproliferative disorder (PTLD) in recipients of islet transplants worldwide. First, a 44-year old recipient of 3 islet infusions developed PTLD 80 months after his initial transplant, presenting with abdominal pain and diffuse terminal ileum thickening on imaging. He was treated with surgical excision, reduction of immunosuppression and rituximab.
The list of things that can be created with 3-D printers keeps getting longer: jewelry, art, guns, food, medical devices and, now, mouse ovaries. Scientists have used a 3-D printer to create a mouse ovary capable of producing healthy offspring. And researchers hope to create replacement human ovaries the same way someday. "It's really the holy grail of bioengineering for regenerative medicine," says Teresa Woodruff, who led the new research published this week in the journal Nature Communications.
|Access to educational information is free to ASHI members. CECs are awarded through an online testing process and are free to ASHI members.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063